- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 289361, 9 pages
Contribution of Ca2+-Dependent Cl− Channels to Norepinephrine-Induced Contraction of Femoral Artery Is Replaced by Increasing EDCF Contribution during Ageing
1Institute of Physiology, Academy of Sciences of the Czech Republic, 14220 Prague 4, Czech Republic
2Institute of Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
Received 27 November 2013; Accepted 16 January 2014; Published 23 February 2014
Academic Editor: Iveta Bernatova
Copyright © 2014 Silvia Liskova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The activation of Ca2+-dependent Cl− channels during norepinephrine-induced contraction of vascular smooth muscle was suggested to depolarize cell membrane and to increase Ca2+ entry. Hypertension and ageing are associated with altered Ca2+ handling including possible activation of Ca2+-dependent Cl− channels. Our study was aimed to determine Ca2+-dependent Cl− channels contribution to norepinephrine-induced contraction during hypertension and ageing. Norepinephrine-induced concentration-response curves of femoral arteries from 6- and 12-month-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were recorded using wire myograph. Pretreatment with Ca2+-dependent Cl- channel inhibitor indanyloxyacetic acid 94 [R(+)-IAA-94](IAA) attenuated norepinephrine-induced contraction in all groups, but relatively more in WKY than SHR arteries. The attenuation of norepinephrine-induced contraction after Ca2+-dependent Cl− channels blockade was partially reduced in 12-month-old WKY rats, but substantially diminished in 12-month-old SHR. IAA effect was enhanced after NO synthase inhibition but decreased by ageing. In 20-month-old WKY rats norepinephrine-induced contraction was not affected by IAA but was almost abolished after cyclooxygenase inhibition by indomethacin or niflumic acid. In conclusion, contribution of Ca2+-dependent Cl− channels to norepinephrine-induced contraction diminished with age, hypertension development, and/or NO synthesis inhibition. Ca2+-dependent Cl− channels are important for maintenance of normal vascular tone while their inactivation/closing might be a pathological mechanism.
The stimulation of vascular smooth muscle cells with norepinephrine leads to the release of Ca2+ from intracellular Ca2+ stores through IP3 pathway (phasic contraction) and thereafter to Ca2+ influx through the opening of L-type voltage-dependent Ca2+ channels (L-VDCC) (tonic contraction). The link between the opening of Ca2+ stores and L-VDCC could be mediated either through the elevation of intracellular Ca2+ levels or might involve other mechanisms such as opening of Cl− channels or closure of K+ channels [1–3]. Brayden and Nelson  showed that pressure-induced contraction of vascular smooth muscle is mediated by Ca2+ influx through L-VDCC and is modulated by a negative feedback pathway involving activation of large-conductance Ca2+-dependent K+ channels. We demonstrated that these K+ channels play an important role in modulating vascular contraction in spontaneous hypertension . Calculated equilibrium potential for Cl− in vascular cells is −26 mV , which is high enough to activate L-VDCC . Furthermore, Ca2+-dependent Cl− channels play a role in Ca2+ uptake to sarcoplasmic reticulum in smooth muscle because the administration of Cl− channel blockers NPPB (5-nitro-2-(3-phenylpropylamino)benzoic acid) and IAA (indanyloxyacetic acid 94 (R(+)-IAA-94) almost completely blocked the Ca2+ uptake . It is evident that Cl− conductance is activated by the enhancement of either Ca2+ release from Ca2+ stores or Ca2+ influx . The Ca2+-dependent Cl− channels exist in two states, open and closed, with a relatively long mean open time. Some of the agents that inhibit Ca2+-dependent Cl− channels interact directly with the open channel, which suggests that the most likely role of Ca2+-dependent Cl− channels in smooth muscle is to produce membrane depolarization and contraction to neurotransmitters . Therefore norepinephrine-induced contraction, which involves the increase of both Ca2+ release from Ca2+ stores and Ca2+ influx should be altered by the blockade of Ca2+-dependent Cl− channels. It has been shown that Ca2+-dependent Cl− channels play a major role in the response to norepinephrine in the portal vein  and mesenteric vein  or in the response of coronary and mesenteric arteries to endothelin . Chloride channel blockers markedly attenuate both rapid and sustained responses of angiotensin II-induced contraction of renal vascular smooth muscle cells and thus contribute to, rather than being the consequence of, the initial rapid contractile response . Pacaud et al.  suggested that the activation of Cl− channels by Ca2+ release from intracellular stores might determine the maximal contraction by influencing the magnitude of membrane depolarization during agonist-induced contraction.
The activation of Ca2+-dependent Cl− channels in aortic smooth muscle cells occurs after caffeine-induced Ca2+ release without Ca2+ influx, but the repetitive activation of Cl− channels depends on Ca2+ influx through L-VDCC. Moreover, the progressive disappearance of caffeine-induced Ca2+ release and Ca2+-dependent Cl− currents in smooth muscle cells treated with NO donors could result from NO-induced inhibition of ryanodine- and caffeine-sensitive Ca2+ channels and/or L-VDCC . This mechanism could be more important for L-NAME-induced contraction of rat coronary arteries, because the changes of Cl− conductance are involved in the L-NAME-induced contraction and the blockade of Cl− channels abolished the L-NAME-induced contractions . On the other hand, there are still confusing results about the involvement of endothelium in the effect of Cl− channel activation. Using small mesenteric arteries Matchkov et al.  and Boedtkjer et al.  showed that there is a Cl− current which is dependent on Ca2+ and cGMP and that the NO is necessary for the activation of this current, which leads to vasomotion and can participate in smooth muscle cell synchronization. This Ca2+-dependent and cGMP-dependent Cl− current is sensitive to Zn2+ ions but less sensitive to conventional Cl− channel blockers.
There are numerous reports on altered vascular function in hypertension and/or ageing in rats (for review see ). These alterations involve impaired endothelium-dependent vascular relaxation due to the attenuated vasodilation induced by nitric oxide [20, 21], β-adrenoceptor stimulation [22, 23], changes in Ca2+ entry and cell Ca2+ handling [24, 25], and so forth. Prominent role of Ca2+ influx through L-VDCC in the control of vascular tone and blood pressure can be demonstrated both under the in vivo and in vitro conditions as we have previously reported in conscious SHR and their isolated femoral arteries [26–28].
Our aim was to quantify the changes in Ca2+-dependent Cl− channel-sensitive component of norepinephrine-induced contraction during the ageing and hypertension. Our hypothesis was that norepinephrine-stimulation of vascular smooth muscle opens/activates Ca2+-dependent Cl− channels in SHR vessels to a larger extent than in those of WKY. The NO synthase inhibition was used to augment the magnitude of norepinephrine-induced contraction as well as to modify the contribution of the above ion channels to this contraction. IAA was used to inhibit Ca2+-dependent Cl− channels in femoral arteries isolated from four groups of rats—adult WKY rats, aged WKY rats, adult SHR, and aged SHR. The second aim of our study was to compare the contribution of Ca2+-dependent Cl− channels and endothelium-derived constricting factor (EDCF) to norepinephrine-induced contraction (including their age-dependent changes). This was possible to examine only in femoral arteries because EDCF is produced in femoral but not in small mesenteric arteries . We investigated femoral arteries of 20-month-old WKY rats after the blockade of Ca2+-dependent Cl− channels by IAA and after the inhibition of cyclooxygenase by indomethacin, which is the main enzyme producing endothelium-derived constricting factor (EDCF).
2. Material and Methods
2.1. General Procedure
Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were sacrificed at the age of 6 months (adult WKY rats and adult SHR) and 12 months (aged WKY rats and aged SHR rats). The second series of experiments was carried out in 20-month-old WKY rats. Animals were housed under standard laboratory conditions (temperature 23 ± 1°C, 12 h light-dark cycle, pelleted ST-1 diet, and tap water ad libitum). All procedures and experimental protocols, which were approved by the Ethical Committee of the Institute of Physiology, Academy of Sciences of Czech Republic, conform to the European Convention on Animal Protection and Guidelines on Research Animal Use.
Animals were anesthetized with ether and blood pressure was measured directly by the puncture of carotid artery. The animals were killed by overdose of CO2 and after decapitation femoral arteries with intact endothelium were cut into 2 mm long segments and placed in a Mulvany-Halpern isometric myograph (M 510A, DMT, Denmark). The myograph chamber was filled with modified Krebs-Henseleit solution (119 mM NaCl, 4.7 mM KCl, 1.17 mM MgSO4, 25 mM NaHCO3, 1.18 mM KH2PO4, 2.5 mM CaCl2, 2 g/L glucose, 37°C) and bubbled with 95% O2 and 5% CO2. The inner arterial diameter was set to be 90% of the diameter predicted for the pressure of 100 mm Hg in the wire myograph. During 30 min of stabilization the vessels were left to achieve their basal tone. To provide the maximal depolarization-induced contraction vessels were incubated with a depolarizing solution (modified Krebs-Henseleit solution with 124 mM K+ but without Na+).
2.2. Experimental Protocol: The Role of Ca2+-Dependent Cl− Channel in Norepinephrine-Induced Contraction
The femoral arteries isolated from adult and aged WKY rats and SHR were studied in the first part of our experiments. Subsequent arterial contractions were induced by cumulative doses of norepinephrine (3.10−8 to 10−4 mol/L) and then acetylcholine-induced relaxations (3.10−8 mol/L and 10−6 mol/L or 3.10−6 mol/L) of norepinephrine-precontracted vessels were measured. One segment with preserved endothelium was studied in each rat. After repeated washing and stabilization of basal tone norepinephrine-induced concentration-response curves were again determined in the same artery segment in the presence of NO synthase inhibitor Nω-nitro-L-arginine (L-NNA, 10−4 mol/L, preincubation time 15 min) or in the presence of Ca2+-dependent Cl− channel blocker indanyloxyacetic acid 94 (R(+)-IAA-94, IAA, 10−5 mol/L, preincubation time 10 min). Finally, these concentration-response curves were measured in the presence of both inhibitors L-NNA and IAA.
2.3. Experimental Protocol: The Changes of Ca2+-Dependent Cl− Channels and EDCF during Ageing
In the second part of our study we used femoral arteries isolated from 20-month-old WKY rats. Arterial contraction induced by cumulative doses of norepinephrine (10−8 to 10−4 mol/L) followed by arterial relaxation elicited by acetylcholine application (10−8 mol/L and 10−6 mol/L) were first measured in the absence of inhibitors. Thereafter norepinephrine-induced concentration-response curves were determined in the presence of Ca2+-dependent Cl− channel blocker indanyloxyacetic acid 94 (R(+)-IAA-94, IAA, 10−5 mol/L, preincubation time 10 min) and after 30 min washing period again in the presence of cyclooxygenase inhibitor indomethacin (IME, 10−5 mol/L, preincubation time 10 min). In another group of vessels norepinephrine-induced concentration-response curves were determined in the presence of niflumic acid (NIFLU, 10−5 mol/L, preincubation time 10 min) which was used as cyclooxygenase inhibitor and Ca2+-dependent Cl− channel blocker.
2.4. Drugs and Statistical Analysis
All chemicals were obtained from Sigma (Heidelberg, Germany). R(+)-IAA-94 and niflumic acid were dissolved in ethanol maintaining the final concentration of ethanol in the chamber under 1%. Indomethacin was dissolved in 170 mM Na2CO3. Logistic model was used for fitting concentration-response curves through the measure values . Pharmacodynamic characteristics—EC50 (half-maximal effective concentration, log mol/L), (maximal contraction, mN/mm), and slope—were calculated for each norepinephrine-induced concentration-response curve. Data are presented as mean ± S.E.M. Statistical analysis was performed with one-way ANOVA and post hoc least significant difference test.
3.1. Basal Characteristics
Blood pressure was higher in SHR than WKY rats without any significant age-dependent increase. The inner diameter of studied femoral arteries was always significantly smaller in SHR than in WKY rats, but it increased with age in both rat strains (Table 1).
3.2. Vascular Responses of Femoral Arteries in Adult and Aged WKY or SHR
The administration of cumulative norepinephrine concentrations to isolated femoral arteries yielded concentration-response curves which were similar in vessels from adult WKY and aged WKY. As far as concentration-response curves of SHR arteries are concerned, the maximal contraction was enhanced in vessels from SHR compared to WKY vessels. Ageing increased the maximal contraction in vessels from SHR only (Figure 1; Table 2). Acetylcholine at the concentration 3.10−8 mol/L relaxed the arteries of adult and aged WKY as well as those of adult SHR by about 50%. The vessels from aged SHR relaxed by 37% only (Table 3). At the higher concentrations of acetylcholine (10−6 mol/L in WKY and 3.10−6 mol/L in SHR) the maximal acetylcholine-induced relaxation of isolated femoral arteries was only slightly attenuated in SHR arteries (Table 3). The wall tension decrease after acetylcholine was greater in SHR vessels, which corresponds to the enhanced arterial contraction in SHR.
3.3. Effect of Ca2+-Dependent Cl− Channels Inhibition on Norepinephrine-Induced Concentration-Response Curves
The inhibition of Ca2+-dependent Cl− channels with IAA almost abolished the norepinephrine-induced contraction of vessels from adult and aged WKY rats and largely reduced the contraction of vessels from adult SHR. The relative inhibitory effect of IAA was surprisingly smallest in femoral arteries isolated from aged SHR (Figure 1; Table 2). The relative contribution of Ca2+-dependent Cl− channel-sensitive component to norepinephrine-induced contraction was 97% in adult WKY, 90% in aged WKY, 80% in adult SHR, but only 55% in aged SHR. The sensitivity to norepinephrine (EC50) was enhanced and was impaired by IAA pretreatment of WKY vessels compared to the control conditions. In contrast, there were no significant changes in norepinephrine sensitivity of concentration-response curves in SHR vessels (Table 2).
3.4. Effect of Ca2+-Dependent Cl− Channels Inhibition on Norepinephrine-Induced Concentration-Response Curves during NO Synthase Inhibition
The inhibition of NO synthase with L-NNA shifted the concentration-response curves to the left in all groups (Figure 1). was substantially increased as compared to the control conditions (Table 2). In the absence of NO synthesis the inhibition of Ca2+-dependent Cl− channels shifted norepinephrine-induced concentration-response curves to the right (Figure 1) and reduced more in WKY than in SHR vessels (Table 2). The relative contribution of Ca2+-dependent Cl− channel-sensitive component represented 93% in adult WKY and 78% in aged WKY,but only 63% in adult SHR and 28% of norepinephrine-induced contraction in aged SHR. Thus, the effect of IAA was again smallest in aged SHR.
3.5. The Changes between Ca2+-Dependent Cl− Channels and EDCF during Ageing
Norepinephrine-induced contraction of vessels isolated from 20-month-old WKY rats were slightly more sensitive to norepinephrine and reached slightly higher maximal contraction values as compared to adult and aged WKY rats. The acetylcholine-induced relaxation was impaired at low concentration of acetylcholine, but it was not changed at higher acetylcholine concentration and reached 79 ± 2% of norepinephrine precontraction (Table 3).
Surprisingly, the application of Ca2+-dependent Cl− channel blocker IAA did not impair the norepinephrine-induced contraction as it was shown in our previous experiments with 6- and 12-month-old rats. As in previous experiments with 6- and 12-month-old rats IAA increased EC50, but the was not altered significantly. The subsequent inhibition of cyclooxygenase with indomethacin almost fully abolished the norepinephrine-induced contraction. In parallel experiments the application of niflumic acid, which is considered to be Ca2+-dependent Cl− channel blocker and cyclooxygenase inhibitor, also abolished the norepinephrine-induced contraction to a similar extent as indomethacin. Our experiments have clearly shown that niflumic acid is a potent cyclooxygenase inhibitor, which cannot be used as a simple Ca2+-dependent Cl− channel blocker (Table 4; Figure 2).
We have investigated the effect of ageing and hypertension on the participation of Ca2+-dependent Cl− channels in norepinephrine-induced contraction of femoral arteries. When evaluating Ca2+-dependent Cl− channel-sensitive component of norepinephrine-induced contraction we have demonstrated that the inhibition of Ca2+-dependent Cl− channels largely impaired the norepinephrine-induced contraction of femoral arteries in all studied groups of rats. Thus, our data are in good agreement with the earlier findings on norepinephrine-induced increase of Cl− conductance in portal vein smooth muscle cells . However, the relative effects were greatest in the arteries of adult WKY rats but smallest in vessels of aged SHR. Our results showed that the contribution of Ca2+-dependent Cl− channels to norepinephrine-induced contraction is reduced during ageing, and hypertension further enhanced this reduction. The mechanism(s) responsible for the residual part of norepinephrine-induced arterial contraction seen mainly in SHR vessels remains to be determined. Resting membrane potential of vascular smooth muscle cells of SHR is increasing during the hypertension development and stays significantly higher compared to normotensive WKY rats . Contrary to our expectations, norepinephrine stimulation of vascular smooth muscle did not open/activate Ca2+-dependent Cl− channels to a larger extent in vascular smooth muscle of SHR.
IAA is a potent Ca2+-dependent Cl− channel inhibitor, but it has also a relatively high affinity to L-VDCC . It is unlikely that IAA affected the L-VDCC significantly in our experiments because a greater IAA effect was disclosed in vessels from adult WKY compared to those from SHR, although L-VDCC plays a more important role in SHR than in WKY . Ca2+-dependent Cl− channels blockers also activate large-conductance Ca2+-activated K+ channels . The concentration used in our experiments was lower as assumed for the activation of Ca2+-activated K+ channels (10−5 mol/L versus 5 × 10−4 mol/L, ). To our knowledge there is no evidence about decreasing influence of Ca2+-activated K+ channels during ageing and further experiments are needed to show if the effect of IAA seen in our study was partially through Ca2+-activated K+ channels.Niflumic acid is also a potent cyclooxygenase inhibitor. A comparison of the effect of indomethacin and niflumic acid clearly shows that both compounds are acting through the inhibition of cyclooxygenase pathway because it was impossible to produce additive changes in contraction by the combination of these two compounds.
We have recently demonstrated  that a considerable part of norepinephrine-induced contraction of rat femoral artery was mediated by endothelium-derived constricting factor (EDCF). This type of arterial contraction can be largely prevented by the pretreatment of vessels with cyclooxygenase inhibitor indomethacin. Indomethacin administration was also capable of inducing a substantial reduction of the already developed arterial contraction. It is important to note that EDCF contribution to norepinephrine-induced arterial contraction was increasing with age and hypertension development . The same was reported for the role of EDCF in the age-dependent impairment of acetylcholine-induced endothelium-dependent vascular relaxation in developing SHR [36, 37]. The mechanisms underlying the age-dependent increase of EDCF formation and/or action remain unclear. It can be speculated that the earlier described age-dependent elevation of intracellular Na+ concentration could augment cyclooxygenase 2 expression as it was demonstrated in cells with increased ratio . Nevertheless, it should be mentioned that EDCF participation in vascular contraction elicited by norepinephrine or high doses of acetylcholine is characteristic for conduit arteries because it is absent in resistance arteries such as small mesenteric vessels . Thus the role of EDCF in blood pressure control remains questionable.
Ca2+-dependent Cl− channels are involved in a major part of norepinephrine-induced contraction of adult and aged WKY arteries, but the contribution of these channels to norepinephrine-induced contraction is decreasing with age and/or hypertension development as was shown using the arteries of 20-month-old WKY rats in which the blockade of Ca2+-dependent Cl− channels was without effect on norepinephrine-induced contraction (Figure 2). This is in contrast with the increasing role of cyclooxygenase-sensitive component of norepinephrine-induced contraction during ageing and hypertension . Thus the participation of Cl− channels in norepinephrine-induced arterial contraction was drastically reduced in aged SHR compared to adult animals, but it was not found in arteries of 20-month-old WKY rats. It seems that the role of Ca2+-dependent Cl− channels is replaced by the increasing influence of EDCF (cyclooxygenase-sensitive component of norepinephrine-induced contraction). It remains to be determined which other cyclooxygenase-sensitive mechanism is responsible for the progressive age-dependent augmentation of norepinephrine-induced contraction of large arteries in ageing and hypertension.
In contrast to the lack of effects of Ca2+-dependent Cl− channel inhibition, the inhibition of cyclooxygenase with indomethacin led to the attenuation of norepinephrine-induced contraction of femoral arteries of 20-month-old WKY rats. In parallel experiments with vessels of these old rats, the application of niflumic acid led to the attenuation of norepinephrine-induced contraction as well. Niflumic acid is considered to be a Ca2+-dependent Cl− channel inhibitor as well as cyclooxygenase inhibitor. Our experiments clearly indicated that niflumic acid is a potent cyclooxygenase inhibitor and that the results obtained with niflumic acid in other studies should be considered carefully. Unfortunately, we were not able to investigate the effect of niflumic acid after the administration of indomethacin on norepinephrine-induced contraction because indomethacin alone almost abolished the contraction to norepinephrine.
The inhibition of NO synthesis pronounced the age- and hypertension-dependent reduction of Ca2+-dependent Cl− channel-sensitive component of norepinephrine-induced contraction. It is possible that the endothelial factors (such as NO) might contribute to the reduction of IAA-sensitive component of norepinephrine-induced contraction. Further studies with more specific compounds are needed to separate the Cl− current dependent on NO as shown by Matchkov et al.  and Boedtkjer et al.  from the Ca2+-dependent Cl− current in vascular smooth muscle cells.
It is important to note that the inhibition of Ca2+-dependent Cl− channels was suggested as a possible therapeutic target in hypertension . In the present study we provide the first evidence that the activation/opening of Ca2+-dependent Cl− channels is important for the maintenance of normal physiological state during norepinephrine-induced contraction, at least in femoral arteries. Further attention should be paid to the interactions of Cl− channels with other ion transporter systems. Recent data indicate that Cl− channels in vascular smooth muscle cells are under the control of inwardly directed Na+, K+, and 2Cl− cotransport (NKCC1). Numerous research groups demonstrated that the inhibitors of this carrier such as bumetanide and furosemide sharply diminished contraction of blood vessels elicited by norepinephrine or other vasoconstrictors (for review see ). Increased nkcc1 mRNA expression and NKCC1 protein content in the aorta of SHR was accompanied by hypomethylation of the nkcc1 gene promoter . It is important to note that the methylation of nkcc1 promoter in normotensive WKY rats was increased with age, whereas in SHR it remained hypomethylated after hypertension development. Both increased nkcc1 expression and inhibitory action of bumetanide on mesenteric artery contractions were increased with age in SHR but not in WKY rats . It would therefore be desirable to study the effects of Ca2+-dependent Cl− channel blockers on norepinephrine-induced vascular contraction in the presence of NKCC1 inhbitors.
In conclusion, our study demonstrated a considerable contribution of Ca2+-dependent Cl− channels to norepinephrine-induced arterial contraction, which diminishes with age, hypertension development, and/or inhibition of NO synthesis. Further studies are needed to provide the evidence for our hypothesis that Ca2+-dependent Cl− channels are important for the maintenance of normal physiological state in the vascular system. The loss or inactivation of these channels during ageing and/or hypertension development could be seen as a pathological mechanism.
5. Limitations of the Study
The contribution of Ca2+-dependent Cl− channels in norepinephrine-induced arterial contraction should be investigated in young normotensive and genetically hypertensive rats to reveal their potential role in the development of hypertension. The contribution of these ion channels to arterial contraction elicited by other vasoconstrictors (such as angiotensin II or endothelin-1) should also be studied. It would be desirable to evaluate the above mechanism in other forms of experimental hypertension.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Skilled assistance of Iva Nahodilová is greatly appreciated. This work was partially supported by the research Grants of Czech Science Foundation (GACR 304/12/0259) and AV0Z 50110509.
- A. P. Somlyo and B. Himpens, “Cell calcium and its regulation in smooth muscle,” FASEB Journal, vol. 3, no. 11, pp. 2266–2276, 1989.
- H. Karaki, H. Ozaki, M. Hori et al., “Calcium movements, distribution, and functions in smooth muscle,” Pharmacological Reviews, vol. 49, no. 2, pp. 157–230, 1997.
- M. J. Berridge, “Smooth muscle cell calcium activation mechanisms,” Journal of Physiology, vol. 586, no. 21, pp. 5047–5061, 2008.
- J. E. Brayden and M. T. Nelson, “Regulation of arterial tone by activation of calcium-dependent potassium channels,” Science, vol. 256, no. 5056, pp. 532–535, 1992.
- S. Líšková, M. Petrová, P. Karen, J. Kuneš, and J. Zicha, “Influence of calcium-dependent potassium channel blockade and nitric oxide inhibition on norepinephrine-induced contractions in two forms of genetic hypertension,” Journal of the American Society of Hypertension, vol. 4, no. 3, pp. 128–134, 2010.
- R. Casteels, K. Kitamura, H. Kuriyama, and H. Suzuki, “The membrane properties of the smooth muscle cells of the rabbit main pulmonary artery,” Journal of Physiology, vol. 271, no. 1, pp. 41–61, 1977.
- K. Kitamura and J. Yamazaki, “Chloride channels and their functional roles in smooth muscle tone in the vasculature,” Japanese Journal of Pharmacology, vol. 85, no. 4, pp. 351–357, 2001.
- N. S. Pollock, M. E. Kargacin, and G. J. Kargacin, “Chloride channel blockers inhibit Ca2+ uptake by the smooth muscle sarcoplasmic reticulum,” Biophysical Journal, vol. 75, no. 4, pp. 1759–1766, 1998.
- P. Pacaud, G. Loirand, C. Mironneau, and J. Mironneau, “Noradrenaline activates a calcium-activated chloride conductance and increases the voltage-dependent calcium current in cultured single cells of rat portal vein,” British Journal of Pharmacology, vol. 97, no. 1, pp. 139–146, 1989.
- W. A. Large and Q. Wang, “Characteristics and physiological role of the Ca2+-activated Cl− conductance in smooth muscle,” American Journal of Physiology, vol. 271, no. 2, pp. C435–C454, 1996.
- D. F. Van Helden, “An α-adrenoceptor-mediated chloride conductance in mesenteric veins of the guinea-pig,” Journal of Physiology, vol. 401, pp. 489–501, 1988.
- U. Klockner and G. Isenberg, “Endothelin depolarizes myocytes from porcine coronary and human mesenteric arteries through a Ca-activated chloride current,” Pflugers Archiv, vol. 418, no. 1-2, pp. 168–175, 1991.
- A. J. Fuller, B. C. Hauschild, R. Gonzalez-Villalobos et al., “Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells,” American Journal of Physiology, vol. 289, no. 4, pp. F760–F767, 2005.
- P. Pacaud, G. Loirand, A. Baron, C. Mironneau, and J. Mironneau, “Ca2+ channel activation and membrane depolarization mediated by Cl− channels in response to noradrenaline in vascular myocytes,” British Journal of Pharmacology, vol. 104, no. 4, pp. 1000–1006, 1991.
- Y. Hirakawa, M. Gericke, R. A. Cohen, and V. M. Bolotina, “Ca2+-dependent Cl− channels in mouse and rabbit aortic smooth muscle cells: regulation by intracellular Ca2+ and NO,” American Journal of Physiology, vol. 277, no. 5, pp. H1732–H1744, 1999.
- J. E. Graves, I. A. Greenwood, and W. A. Large, “Tonic regulation of vascular tone by nitric oxide and chloride ions in rat isolated small coronary arteries,” American Journal of Physiology, vol. 279, no. 6, pp. H2604–H2611, 2000.
- V. V. Matchkov, C. Aalkjaer, and H. Nilsson, “A cyclic GMP-dependent calcium-activated chloride current in smooth-muscle cells from rat mesenteric resistance arteries,” Journal of General Physiology, vol. 123, no. 2, pp. 121–134, 2004.
- D. M. B. Boedtkjer, V. V. Matchkov, E. Boedtkjer, H. Nilsson, and C. Aalkjaer, “Vasomotion has chloride-dependency in rat mesenteric small arteries,” Pflugers Archiv, vol. 457, no. 2, pp. 389–404, 2008.
- M. Pintérová, J. Kuneš, and J. Zicha, “Altered neural and vascular mechanisms in hypertension,” Physiological Research, vol. 60, pp. 381–402, 2011.
- Y. Shirasaki, C. Su, and T. J.-F. Lee, “Endothelial modulation of vascular relaxation to nitrovasodilators in aging and hypertension,” Journal of Pharmacology and Experimental Therapeutics, vol. 239, no. 3, pp. 861–866, 1986.
- F. Li and I. G. Joshua, “Decreased arteriolar endothelium-derived relaxing factor production during the development of genetic hypertension,” Clinical and Experimental Hypertension, vol. 15, no. 3, pp. 511–526, 1993.
- S. Fujimoto, Y. Dohi, and K. Aoki, “Diminished β-adrenoceptor-mediated relaxation of arteries from spontaneously hypertensive rats before and during development of hypertension,” European Journal of Pharmacology, vol. 136, no. 2, pp. 179–187, 1987.
- S. Arribas, J. Marin, A. Ponte, G. Balfagon, and M. Salaices, “Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension,” Journal of Pharmacology and Experimental Therapeutics, vol. 270, no. 2, pp. 520–527, 1994.
- N. J. Rusch and K. Hermsmeyer, “Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats,” Circulation Research, vol. 63, no. 6, pp. 997–1002, 1988.
- R. H. Cox and I. M. Lozinskaya, “Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rats,” Hypertension, vol. 26, no. 6, pp. 1060–1064, 1995.
- L. Paulis, S. Líšková, M. Pintérová, Z. Dobešová, J. Kuneš, and J. Zicha, “Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment,” Acta Physiologica, vol. 191, pp. 255–266, 2007.
- M. Pintérová, S. Líšková, Z. Dobešová, M. Behuliak, J. Kuneš, and J. Zicha, “Impaired control of L-type voltage-dependent calcium channels in experimental hypertension,” Physiological Research, vol. 58, supplement 2, pp. S43–S54, 2009.
- M. Pintérová, P. Karen, J. Kuneš, and J. Zicha, “Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertussis toxin,” Journal of Hypertension, vol. 28, no. 5, pp. 969–978, 2010.
- L. Paulis, J. Zicha, J. Kunes et al., “Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor,” Hypertension Research, vol. 31, no. 4, pp. 793–803, 2008.
- J. Janáček and I. Prášil, “Quantification of plant frost injury by nonlinear fitting of an S-shaped function,” Cryoletters, vol. 12, pp. 47–52, 1991.
- D. W. Cheung, “Membrane potential of vascular smooth muscle and hypertension in spontaneously hypertensive rats,” Canadian Journal of Physiology and Pharmacology, vol. 62, no. 8, pp. 957–960, 1984.
- J. M. Doughty, A. L. Miller, and P. D. Langton, “Non-specificity of chloride channel blockers in rat cerebral arteries: block of the L-type calcium channel,” Journal of Physiology, vol. 507, no. 2, pp. 433–439, 1998.
- I. A. Greenwood and N. Leblanc, “Overlapping pharmacology of Ca2+-activated Cl− and K+ channels,” Trends in Pharmacological Sciences, vol. 28, no. 1, pp. 1–5, 2007.
- C. Toma, I. A. Greenwood, R. M. Helliwell, and W. A. Large, “Activation of potassium currents by inhibitors of calcium-activated chloride conductance in rabbit portal vein smooth muscle cells,” British Journal of Pharmacology, vol. 118, no. 3, pp. 513–520, 1996.
- S. Líšková, M. Petrová, K. Petr, J. Kuneš, and J. Zicha, “Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery,” European Journal of Pharmacology, vol. 667, no. 1–3, pp. 265–270, 2011.
- P. A. C. Watt and H. Thurston, “Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rats,” Journal of Hypertension, vol. 7, no. 8, pp. 661–666, 1989.
- T. Koga, Y. Takata, K. Kobayashi, S. Takishita, Y. Yamashita, and M. Fujishima, “Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat,” Hypertension, vol. 14, no. 5, pp. 542–548, 1989.
- S. V. Koltsova, Y. Trushina, M. Haloui et al., “Ubiquitous -sensitive transcriptome in mammalian cells: evidence for -independent excitation-transcription coupling,” PLoS ONE, vol. 7, Article ID e38032, 2012.
- K. Goto, F. R. Edwards, and C. E. Hill, “Depolarization evoked by acetylcholine in mesenteric arteries of hypertensive rats attenuates endothelium-dependent hyperpolarizing factor,” Journal of Hypertension, vol. 25, no. 2, pp. 345–359, 2007.
- S. N. Orlov, S. V. Koltsova, J. Tremblay, M. B. Baskakov, and P. Hamet, “NKCC1 and hypertension: role in the regulation of vascular smooth muscle contractions and myogenic tone,” Annals of Medicine, vol. 44, supplement 1, pp. S111–S118, 2012.
- H.-A. Lee, I. Baek, Y. M. Seok et al., “Promoter hypomethylation upregulates Na+-K+-2Cl− cotransporter 1 in spontaneously hypertensive rats,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 252–257, 2010.
- H.-M. Cho, H.-A. Lee, H. Y. Kim, H. S. Han, and I. K. Kim, “Expression of Na+-K+-2Cl cotransporter 1 is epigenetically regulated during postnatal development of hypertension,” American Journal of Hypertension, vol. 24, no. 12, pp. 1286–1293, 2011.